https://www.orthoworld.com
ORTHOWORLD
Anika Therapeutics Transforms to Hybrid Commercial Model
By Mike Evers
In 3Q19, Anika completed the buildout of their U.S. hybrid commercial model while achieving double-digit revenue growth driven by MONOVISC and CINGAL.